Cargando…

N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein

The combination of three or more antiviral agents that act on different targets is known as highly active antiretroviral therapy (HAART), which is widely used to control HIV infection. However, because drug resistance and adverse effects occur after long-term administration, an increasing number of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Jiayin, Liang, Taizhen, Wu, Junyan, Yu, Fei, He, Xiaoyang, Tian, Yuanxin, Xie, Lan, Jiang, Shibo, Liu, Shuwen, Li, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688628/ https://www.ncbi.nlm.nih.gov/pubmed/31427969 http://dx.doi.org/10.3389/fphar.2019.00859

Ejemplares similares

Membrane topology analysis of HIV-1 envelope glycoprotein gp41
por: Liu, Shujun, et al.
Publicado: (2010)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
por: Sanders, Rogier W, et al.
Publicado: (2004)

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
por: Yu, Fei, et al.
Publicado: (2013)

Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein
por: Joshi, Vinita R., et al.
Publicado: (2020)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Structure based sequence analysis & epitope prediction of gp41 HIV1 envelope glycoprotein isolated in Pakistan
por: Jafri, Syyada Samra, et al.
Publicado: (2012)

Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
por: Herschhorn, Alon, et al.
Publicado: (2016)

Retraction: Structure based sequence analysis & epitope prediction of gp41 HIV1 envelope glycoprotein isolated in Pakistan
por: Jafri, Syyada Samra, et al.
Publicado: (2012)

Rational Design of A Novel Small-Molecule HIV-1 Inactivator Targeting Both gp120 and gp41 of HIV-1
por: Pu, Jing, et al.
Publicado: (2021)

An entry-competent intermediate state of the HIV-1 envelope glycoproteins
por: Herschhorn, Alon, et al.
Publicado: (2017)

Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?
por: Teixeira, Cátia, et al.
Publicado: (2016)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
por: Araújo, Leonardo Augusto Luvison, et al.
Publicado: (2013)

HIV-1 Envelope Glycoprotein Variable Loops Are Indispensable for Envelope Structural Integrity and Virus Entry
por: Yuan, Tingting, et al.
Publicado: (2013)

Fejerlectin, a Lectin-like Peptide from the Skin of Fejervarya limnocharis, Inhibits HIV-1 Entry by Targeting Gp41
por: Xiong, Weichen, et al.
Publicado: (2021)

Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer
por: Alsahafi, Nirmin, et al.
Publicado: (2015)

HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
por: Qi, Qianqian, et al.
Publicado: (2017)

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
por: Kong, Leopold, et al.
Publicado: (2013)

HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes
por: Levast, Benoît, et al.
Publicado: (2017)

Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes
por: Zhou, Xueyuan, et al.
Publicado: (2016)

Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120
por: Korkut, Anil, et al.
Publicado: (2012)

The Conserved Residue Arg46 in the N-Terminal Heptad Repeat Domain of HIV-1 gp41 Is Critical for Viral Fusion and Entry
por: Wang, Xiaoyi, et al.
Publicado: (2012)

Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission
por: Ramakrishnan, Rajesh, et al.
Publicado: (2006)

Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1
por: Mühle, Michael, et al.
Publicado: (2017)

Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles
por: Kumar, Sonu, et al.
Publicado: (2021)

Correction: Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer
Publicado: (2015)

Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines
por: Mayer-Blackwell, Koshlan, et al.
Publicado: (2022)

Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein
por: Vassell, Russell, et al.
Publicado: (2015)

A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
por: Herschhorn, Alon, et al.
Publicado: (2014)

Neutralizing Antibodies Targeting HIV-1 gp41
por: Caillat, Christophe, et al.
Publicado: (2020)

HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies
por: Wang, Ji, et al.
Publicado: (2011)

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
por: Wang, Xinling, et al.
Publicado: (2021)

gp41: HIV's shy protein
por: Zwick, Michael B, et al.
Publicado: (2004)

Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics
por: Lassen, Kara G., et al.
Publicado: (2009)

Peptides presenting the binding site of human CD4 for the HIV-1 envelope glycoprotein gp120
por: Meier, Julia, et al.
Publicado: (2012)

Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
por: Duchemin, Maxence, et al.
Publicado: (2020)

Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients
por: Marcelino, Rute, et al.
Publicado: (2021)

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
por: Xu, Lin, et al.
Publicado: (2021)

Immunisation with the membrane proximal external region of gp41 of HIV-1 grafted into the transmembrane envelope protein of a gammaretrovirus
por: Strasz, N, et al.
Publicado: (2012)

Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope
por: Penn-Nicholson, Adam, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_mituk4bf7orj4aqq7ptocthka7